KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dynavax Technologies (DVAX) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to $28.2 million.

  • Dynavax Technologies' Net Income towards Common Stockholders rose 4923.68% to $28.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$40.9 million, marking a year-over-year decrease of 27780.24%. This contributed to the annual value of $27.3 million for FY2024, which is 52743.78% up from last year.
  • As of Q3 2025, Dynavax Technologies' Net Income towards Common Stockholders stood at $28.2 million, which was up 4923.68% from $20.0 million recorded in Q2 2025.
  • Dynavax Technologies' Net Income towards Common Stockholders' 5-year high stood at $128.8 million during Q2 2022, with a 5-year trough of -$96.1 million in Q1 2025.
  • Its 5-year average for Net Income towards Common Stockholders is $19.4 million, with a median of $15.6 million in 2023.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first skyrocketed by 311917.81% in 2024, then plummeted by 100192.64% in 2025.
  • Dynavax Technologies' Net Income towards Common Stockholders (Quarter) stood at $99.8 million in 2021, then plummeted by 32.12% to $67.7 million in 2022, then plummeted by 99.68% to $219000.0 in 2023, then surged by 3119.18% to $7.0 million in 2024, then surged by 299.4% to $28.2 million in 2025.
  • Its last three reported values are $28.2 million in Q3 2025, $20.0 million for Q2 2025, and -$96.1 million during Q1 2025.